A PLAN FOR TYPE 1 DIABETES
Insulin-dependent diabetes can be cured by replacement pancreatic islets. Pancreatic islets are the clusters of cells responsible for regulating healthy levels of glucose in the blood.
Seraxis’ unique cell replacement therapy, SR-01 combines the two essential components:
- Lab-grown human islets that are as potent as islets from a healthy pancreas
- A technology to allow the implant of a therapeutic dose of replacement islets without the need for immune suppression
Both components were developed and are manufactured in a clinically acceptable manner that is practical for the millions of patients in need.
Goal driven technology
The Seraxis team of scientific and medical experts developed novel cell and encapsulation technologies. Our main goal is to bring a practical cell therapy for insulin-dependent diabetes to the clinic and provide a long-term normalization of blood glucose to patients that does not require the use of immuno-suppression.